PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2010 | 8 | 6 | 1216-1222
Article title

Comparison of IFCC and NGSP methods for determination of glycated haemoglobin using advanced regression techniques

Content
Title variants
Languages of publication
EN
Abstracts
EN
The objective of this work was a correct statistical comparison of two assay methods for determination of glycated haemoglobin HbA1c. The immunoturbidimetric determination of HbA1c was performed in two ways: using an automatic analyser Hitachi 912, calibrated according to the IFCC reference system (International Federation of Clinical Chemistry and Laboratory Medicine) and using an analyser Advia 1200 and the NGSP reference system (National Glycohaemoglobin Standardization Program). For statistical comparison of these two analytical methods several advanced regression methods were used, which respect random errors of both compared methods. Specifically, Deming regression with and without weights, orthogonal regression, and Passing-Bablok regression were employed. The results demonstrate that the investigated analytical assay methods do not correspond to each other. The summarized results indicate usefulness of better harmonisation of two existing reference systems.
Publisher

Journal
Year
Volume
8
Issue
6
Pages
1216-1222
Physical description
Dates
published
1 - 12 - 2010
online
8 - 10 - 2010
Contributors
  • Department of Chemistry, University of SS. Cyril and Methodius, Trnava, SK-917 01, Slovak Republic
author
  • Department of Chemistry, University of SS. Cyril and Methodius, Trnava, SK-917 01, Slovak Republic, jan.mocak@ucm.sk
  • Department of Chemistry, University of SS. Cyril and Methodius, Trnava, SK-917 01, Slovak Republic
author
  • Analytical — diagnostic laboratory, Prešov, SK-080 01, Slovak Republic
References
  • [1] D.B. Sacks, Clin. Chem. 49, 1245 (2003) http://dx.doi.org/10.1373/49.8.1245[Crossref]
  • [2] A. Lapolla, P. Traldi, D. Fedele, Clin. Biochem. 38, 103 (2005) http://dx.doi.org/10.1016/j.clinbiochem.2004.09.007[Crossref]
  • [3] M. Penttilä, T. Halonen, K. Punnonen, U. Tiikkainen, Scand. J. Clin. Lab. Invest. 65, 453 (2005) http://dx.doi.org/10.1080/00365510510025809[Crossref]
  • [4] S. Manley, W.G. John, S. Marshall, Diabet. Med. 21, 673 (2004) http://dx.doi.org/10.1111/j.1464-5491.2004.01311.x[Crossref]
  • [5] Consensus Committee: J. Hicks, M. Muller, M. Panteghini, G. John, L. Deeb, J. Buse, D.M. Nathan, R. Kahn, E. Ferrannini, R. Heine, M. Silink, J.C. Mbanya, Diabetes Care 30, 2399 (2007) http://dx.doi.org/10.2337/dc07-9925[Crossref]
  • [6] A. Geistanger, S. Arends, Ch. Berding, T. Hoshino, J.O. Jeppsson, R. Little, C. Siebelder, C. Weykamp, Clin. Chem. 54, 1379 (2008) http://dx.doi.org/10.1373/clinchem.2008.103556[Crossref]
  • [7] J.O. Jeppsson, U. Kobold, J. Barr, A. Finke, W. Hoelzel, T. Hoshino, K. Miedema, A. Mosca, P. Mauri, R. Paroni, L. Thienpont, M. Umemoto, C. Weykamp, Clin. Chem. Lab. Med. 40, 78 (2002) http://dx.doi.org/10.1515/CCLM.2002.016[Crossref]
  • [8] H.G. Schneider, I. Goodall, P.G. Colman, M. McLean, G. Barker, Int. Med. J. 37, 213 (2007) http://dx.doi.org/10.1111/j.1445-5994.2006.01302.x[Crossref]
  • [9] K. Paisooksantivatana, A. Kongsomgan, L. Leohirun, K. Atamasirikul, M. Kunakorn, Diabetes Res. Clin. Pract. 83, 43 (2009) http://dx.doi.org/10.1016/j.diabres.2008.11.028[Crossref]
  • [10] K. Paisooksantivatana, A. Kongsomgan, K. Khupulsup, Diabetes Res. Clin. Pract. 85, 22 (2009) http://dx.doi.org/10.1016/j.diabres.2009.06.005[Crossref]
  • [11] W. Hoelzel, C. Weykamp, J.O. Jeppsson, K. Miedema, J.R. Barr, I. Goodall, T. Hoshino, W.G. John, U. Kobold, R. Little, A. Mosca, P. Mauri, R. Paroni, F. Susanto, I. Takei, L. Thienpont, M. Umemoto, H.M. Wiedmeyer, Clin. Chem. 50, 166 (2004) http://dx.doi.org/10.1373/clinchem.2003.024802[Crossref]
  • [12] Roche Diagnostics GmbH D-M, Cobas Integra 400/700/800: Hemoglobin A1C hemolysate application standardized according to IFCC (Roche Diagnostics Corporation, Indianapolis, IN, USA, 2002)
  • [13] J. Mocak, B. Balla, A. Bobrowski, P. Blazicek, Chem. Pap. 57, 143 (2003)
  • [14] K. Linnet, Clin. Chem. 39, 424 (1993)
  • [15] H. Passing, W. Bablok, J. Clin. Chem. Clin. Biochem. 21, 709 (1983)
  • [16] H. Passing, W. Bablok, J. Clin. Chem. Clin. Biochem. 22, 431 (1984)
  • [17] W. Bablok, H. Passing, R. Bender, B. Schneider, J. Clin. Chem. Clin. Biochem. 26, 783 (1988)
  • [18] J.M. Bland, D.G. Altman, Stat. Methods Med. Res. 8, 135 (1999) http://dx.doi.org/10.1191/096228099673819272[Crossref]
  • [19] Analyse-it for Microsoft Excel ver. 2.12 (Analyse-it Software, Ltd., United Kingdom, 1997–2010) http://www.analyse-it.com
  • [20] Medcalc ver. 10.4.0.0. (MedCalc Software bvba, Mariakerke, Belgium, 2005–2010) http://medcalc.be
  • [21] JMP 8 (SAS Institute Inc., Cary, NC, USA, 2005) http://jmp.com
  • [22] K. Linnet, Clin. Chem. 45, 882 (1999)
  • [23] G.S. Dhatt, M.M. Agarwal, B. Bishawi, Clin. Chim. Acta 358, 81 (2005) http://dx.doi.org/10.1016/j.cccn.2005.02.009[Crossref]
  • [24] A. Adamikova, J. Bakala, J. Bernatek, J. Rybka, S. Svacina, Ann. Nuc. Med. 20, 615 (2006) http://dx.doi.org/10.1007/BF02984659[Crossref]
  • [25] J.M. Bland, D.G. Altman, Lancet 307 (1986) [Crossref]
  • [26] D. Stöckl, K. Dewitte, L.M. Thienpont, Clin. Chem. 44, 2340 (1998)
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.-psjd-doi-10_2478_s11532-010-0096-x
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.